Where Success Begins

Science-led integrated drug discovery: medicinal and synthetic chemistry, computational chemistry, in vitro biosciences, DMPK, compound management and diversity and fragment libraries.

Read more

About Us

BioAscent is a leading provider of integrated drug discovery services

Founded in 2013, BioAscent is a leading provider of integrated drug discovery services based at the former Organon / MSD R&D site in Newhouse, Scotland, UK. Our drug discovery services include de novo assay development, target analysis and bespoke screening strategies, compound screening (including HTS), medicinal and synthetic chemistry, computational chemistry and compound management, all with access to in-house diversity and fragment libraries.

Read more

News

BioAscent featured in Business Focus Magazine

22 August 2025


We are pleased to share that BioAscent has been profiled in the latest issue of Business Focus Magazine. With insight fr...

Read more

From Cybersecurity to Chemistry: Applying anomaly detection to expand a fragment collection

25 June 2025


In drug discovery, the quality and diversity of our screening libraries are paramount. In fragment-based drug discovery,...

Read more

Working with Asynt

25 June 2025


At BioAscent, we have invested over £3 million in R&D equipment since 2020, and our commitment to innovation and sus...

Read more

BioAscent expands compound library portfolio with chemogenomic set to accelerate drug discovery

21 May 2025


BioAscent is pleased to announce the acquisition of a high-value chemogenomic compound library which significantly enhan...

Read more

Integrated Drug Discovery


Science-led drug discovery

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact